Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'precipitated withdrawal' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 178 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Bespalov, AY; Medvedev, IO; Sukhotina, IA; Zvartau, EE
      Effects of the NMDA receptor antagonist, D-CPPene, on sensitization to theoperant decrement produced by naloxone in morphine-treated rats

      BEHAVIOURAL PHARMACOLOGY
    2. Gracy, KN; Dankiewicz, LA; Koob, GF
      Opiate withdrawal-induced Fos immunoreactivity in the rat extended amygdala parallels the development of conditioned place aversion

      NEUROPSYCHOPHARMACOLOGY
    3. Swift, W; Hall, W; Teesson, C
      Characteristics of DSM-IV and ICD-10 cannabis dependence among Australian adults: results from the National Survey of Mental Health and Wellbeing

      DRUG AND ALCOHOL DEPENDENCE
    4. Nicholson, KL; Balster, RL
      GHB: a new and novel drug of abuse

      DRUG AND ALCOHOL DEPENDENCE
    5. Kest, B; Palmese, CA; Hopkins, E; Adler, M; Juni, A
      Assessment of acute and chronic morphine dependence in male and female mice

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    6. Darmani, NA
      Cannabinoids of diverse structure inhibit two DOI-induced 5-HT2A receptor-mediated behaviors in mice

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    7. Langerman, L; Piscoun, B; Bansinath, M; Shemesh, Y; Turndorf, H; Grant, GJ
      Quantifiable dose-dependent withdrawal after morphine discontinuation in arat model

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    8. Kotlinska, J
      Attenuation of morphine dependence and withdrawal by glycine(B) site antagonists in rats

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    9. Lamarque, S; Taghzouti, K; Simon, H
      Chronic treatment with Delta(9)-tetrahydrocannabinol enhances the locomotor response to amphetamine and heroin. Implications for vulnerability to drug addiction

      NEUROPHARMACOLOGY
    10. Le Guen, S; Gestreau, C; Besson, JM
      Sensitivity to naloxone of the behavioral signs of morphine withdrawal andc-Fos expression in the rat CNS: A quantitative dose-response analysis

      JOURNAL OF COMPARATIVE NEUROLOGY
    11. Parsons, CG
      NMDA receptors as targets for drug action in neuropathic pain

      EUROPEAN JOURNAL OF PHARMACOLOGY
    12. Aceto, MD; Scates, SM; Martin, BB
      Spontaneous and precipitated withdrawal with a synthetic cannabinoid, WIN 55212-2

      EUROPEAN JOURNAL OF PHARMACOLOGY
    13. Saiepour, MH; Semnanian, S; Fathollahi, Y
      Occurrence of morphine tolerance and dependence in the nucleus paragigantocellularis neurons

      EUROPEAN JOURNAL OF PHARMACOLOGY
    14. Zhu, HB; Barr, GA
      Opiate withdrawal during development: are NMDA receptors indispensable?

      TRENDS IN PHARMACOLOGICAL SCIENCES
    15. Kalinichev, M; Easterling, KW; Holtzman, SG
      Early neonatal experience of Long-Evans rats results in long-lasting changes in morphine tolerance and dependence

      PSYCHOPHARMACOLOGY
    16. Anraku, T; Ikegaya, Y; Matsuki, N; Nishiyama, N
      Withdrawal from chronic morphine administration causes prolonged enhancement of immobility in rat forced swimming test

      PSYCHOPHARMACOLOGY
    17. Bisaga, A; Comer, SD; Ward, AS; Popik, P; Kleber, HD; Fischman, MW
      The NMDA antagonist memantine attenuates the expression of opioid physicaldependence in humans

      PSYCHOPHARMACOLOGY
    18. Rada, P; Jensen, K; Hoebel, BG
      Effects of nicotine and mecamylamine-induced withdrawal on extracellular dopamine and acetylcholine in the rat nucleus accumbens

      PSYCHOPHARMACOLOGY
    19. Fendt, M; Mucha, RF
      Anxiogenic-like effects of opiate withdrawal seen in the fear-potentiated startle test, an interdisciplinary probe far drug-related motivational states

      PSYCHOPHARMACOLOGY
    20. Pertwee, RG
      Neuropharmacology and therapeutic potential of cannabinoids

      ADDICTION BIOLOGY
    21. Bisaga, A; Popik, P; Bespalov, AY; Danysz, W
      Therapeutic potential of NMDA receptor antagonists in the treatment of alcohol and substance use disorders

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    22. Wala, EP; Sloan, JW; Jing, X
      Pharmacokinetics of the peripheral benzodiazepine receptor antagonist, PK 11195, in rats. The effect of dose and gender

      PHARMACOLOGICAL RESEARCH
    23. Bespalov, AY; Zvartau, EE; Balster, RL; Beardsley, PM
      Effects of N-methyl-D-aspartate receptor antagonists on reinstatement of cocaine-seeking behavior by priming injections of cocaine or exposures to cocaine-associated cues in rats

      BEHAVIOURAL PHARMACOLOGY
    24. Ator, NA; Weerts, EM; Kaminski, BJ; Kautz, MA; Griffiths, RR
      Zaleplon and triazolam physical dependence assessed across increasing doses under a once-daily dosing regimen in baboons

      DRUG AND ALCOHOL DEPENDENCE
    25. Bisaga, A; Popik, P
      In search of a new pharmacological treatment for drug and alcohol addiction: N-methyl-D-aspartate (NMDA) antagonists

      DRUG AND ALCOHOL DEPENDENCE
    26. Darmani, NA; Pandya, DK
      Involvement of other neurotransmitters in behaviors induced by the cannabinoid CB1 receptor antagonist SR 141716A in naive mice

      JOURNAL OF NEURAL TRANSMISSION
    27. Brown, CH; Russell, JA; Leng, G
      Opioid modulation of magnocellular neurosecretory cell activity

      NEUROSCIENCE RESEARCH
    28. Sloan, JW; Wala, EP; Jing, X; Holtman, JR
      The pharmacodynamics of PK 11195 in diazepam-dependent male and female rats

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    29. Popik, P; Kozela, E; Danysz, W
      Clinically available NMDA receptor antagonists memantine and dextromethorphan reverse existing tolerance to the antinociceptive effects of morphine in mice

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    30. Rubino, T; Massi, P; Vigano, D; Fuzio, D; Parolaro, D
      Long-term treatment with SR141716A, the CB1 receptor antagonist, influences morphine withdrawal syndrome

      LIFE SCIENCES
    31. Brandt, MR; France, CP
      Chronic l-alpha-acetylmethadol (LAAM) in rhesus monkeys: Tolerance and cross-tolerance to the antinociceptive, ventilatory, and rate-decreasing effects of opioids

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    32. Di Marzo, V; Berrendero, F; Bisogno, T; Gonzalez, S; Cavaliere, P; Romero, J; Cebeira, M; Ramos, JA; Fernandez-Ruiz, JJ
      Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of Delta(9)-tetrahydrocannabinol-tolerant rats

      JOURNAL OF NEUROCHEMISTRY
    33. Barr, MC; Billaud, JN; Selway, DR; Huitron-Resendiz, S; Osborn, KG; Henriksen, SJ; Phillips, TR
      Effects of multiple acute morphine exposures on feline immunodeficiency virus disease progression

      JOURNAL OF INFECTIOUS DISEASES
    34. Kishioka, S; Paronis, CA; Woods, JH
      Acute dependence on, but not tolerance to, heroin and morphine as measuredby respiratory effects in rhesus monkeys

      EUROPEAN JOURNAL OF PHARMACOLOGY
    35. Milanes, MV; Laorden, ML
      Changes in catecholaminergic pathways innervating the rat heart ventricle during morphine dependence. Involvement of alpha(1)- and alpha(2)-adrenoceptors

      EUROPEAN JOURNAL OF PHARMACOLOGY
    36. Elliot, EE; White, JM
      Long-term abecarnil administration produces tolerance and withdrawal signsin the rat

      EUROPEAN JOURNAL OF PHARMACOLOGY
    37. Nakagawa, T; Masuda, T; Watanabe, T; Minami, M; Satoh, M
      Possible involvement of the locus coeruleus in inhibition by prostanoid EP3 receptor-selective agonists of morphine withdrawal syndrome in rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    38. Trujillo, KA
      Are NMDA receptors involved in opiate-induced neural and behavioral plasticity? A review of preclinical studies

      PSYCHOPHARMACOLOGY
    39. David, V; Cazala, P
      Anatomical and pharmacological specificity of the rewarding effect elicited by microinjections of morphine into the nucleus accumbens of mice

      PSYCHOPHARMACOLOGY
    40. Costa, B; Giagnoni, G; Colleoni, M
      Precipitated and spontaneous withdrawal in rats tolerant to anandamide

      PSYCHOPHARMACOLOGY
    41. Cuellar, B; Fernandez, AP; Lizasoain, I; Moro, MA; Lorenzo, P; Bentura, ML; Rodrigo, J; Leza, JC
      Up-regulation of neuronal NO synthase immunoreactivity in opiate dependence and withdrawal

      PSYCHOPHARMACOLOGY
    42. Langerman, L; Steingart, RA; Margolis, A; Yanai, J
      A method of reducing the opioid withdrawal intensity using progressively increasing doses of naloxone

      JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
    43. Dravolina, OA; Medvedev, IO; Bespalov, AY
      Behavioural effects of glutamate receptor agonists in morphine-dependent rats

      BEHAVIOURAL PHARMACOLOGY
    44. Diana, M; Muntoni, AL; Pistis, M; Melis, M; Gessa, GL
      Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal

      EUROPEAN JOURNAL OF NEUROSCIENCE
    45. Budziszewska, B; Leskiewicz, M; Jaworska-Feil, L; Lason, W
      The effect of N-nitro-L-arginine methyl ester on morphine-induced changes in the plasma corticosterone and testosterone levels in mice

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    46. Arasteh, K; Poudevida, S; Farre, M; Roset, PN; Cami, J
      Response patterns of the Spanish version of the 49-item short form of the Addiction Research Center Inventory after the use of sedatives, stimulants,and opioids

      DRUG AND ALCOHOL DEPENDENCE
    47. Cutler, DJ; Mundey, MK; Mason, R
      Electrophysiological effects of opioid receptor activation on Syrian hamster suprachiasmatic nucleus neurones in vitro

      BRAIN RESEARCH BULLETIN
    48. Leng, G; Brown, CH; Russell, JA
      Physiological pathways regulating the activity of magnocellular neurosecretory cells

      PROGRESS IN NEUROBIOLOGY
    49. Wala, EP; Sloan, JW; Jing, X
      Substantia nigra: The involvement of central and peripheral benzodiazepinereceptors in physical dependence on diazepam as evidenced by behavioral and EEG effects

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    50. Stock, H; Ford, K; Biscardi, R; Wilson, MA
      Lack of sex differences in anxiety behaviors during precipitated benzodiazepine withdrawal in rats

      PHYSIOLOGY & BEHAVIOR
    51. Ambrosio, E; Martin, S; Garcia-Lecumberri, C; Crespo, JA
      The neurobiology of cannabinoid dependence: Sex differences and potential interactions between cannabinoid and opioid systems

      LIFE SCIENCES
    52. Eissenberg, T; Stitzer, ML; Bigelow, GE; Buchhalter, AR; Walsh, SL
      Relative potency of levo-alpha-acetylmethadol and methadone in humans under acute dosing conditions

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    53. Semenova, S; Danysz, W; Bespalov, A
      Low-affinity NMDA receptor channel blockers inhibit acquisition of intravenous morphine self-administration in naive mice

      EUROPEAN JOURNAL OF PHARMACOLOGY
    54. Medvedev, IO; Dravolina, OA; Bespalov, AY
      Differential effects of nitric oxide synthase inhibitor, 7-nitroindazole, on discriminative stimulus and somatic effects of naloxone in morphine-dependent rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    55. Farzin, D
      Modification of naloxone-induced withdrawal signs by dextromethorphan in morphine-dependent mice

      EUROPEAN JOURNAL OF PHARMACOLOGY
    56. Chan, R; Irvine, R; White, J
      Cardiovascular changes during morphine administration and spontaneous withdrawal in the rat

      EUROPEAN JOURNAL OF PHARMACOLOGY
    57. Celerier, E; Laulin, JP; Larcher, A; Le Moal, M; Simonnet, G
      Evidence for opiate-activated NMDA processes masking opiate analgesia in rats

      BRAIN RESEARCH
    58. Manzanares, J; Corchero, J; Romero, J; Fernandez-Ruiz, JJ; Ramos, JA; Fuentes, JA
      Pharmacological and biochemical interactions between opioids and cannabinoids

      TRENDS IN PHARMACOLOGICAL SCIENCES
    59. Mintzer, RZ; Stoller, KB; Griffiths, RR
      A controlled study of flumazenil-precipitated withdrawal in chronic low-dose benzodiazepine users

      PSYCHOPHARMACOLOGY
    60. BOUCHEZ J; BEAUVERIE P; TOUZEAU D
      SUBSTITUTION WITH BUPRENORPHINE IN METHADONE-DEPENDENT AND MORPHINE-SULFATE-DEPENDENT PATIENTS - PRELIMINARY-RESULTS

      European addiction research
    61. ERNSBERGER P
      THE I-1-IMIDAZOLINE RECEPTOR AGONIST MOXONIDINE - MOLECULAR, CELLULARAND ORGANISMIC ACTIONS

      Reviews in contemporary pharmacotherapy
    62. HIGHFIELD DA; GRANT S
      NG-NITRO-L-ARGININE, AN NOS INHIBITOR, REDUCES TOLERANCE TO MORPHINE IN THE RAT LOCUS-COERULEUS

      Synapse
    63. SPANAGEL R; KIRSCHKE C; TRETTER F; HOLSBOER F
      FORCED OPIATE WITHDRAWAL UNDER ANESTHESIA AUGMENTS AND PROLONGS THE OCCURRENCE OF WITHDRAWAL SIGNS IN RATS

      Drug and alcohol dependence
    64. FUDALA PJ; YU E; MACFADDEN W; BOARDMAN C
      EFFECTS OF BUPRENORPHINE AND NALOXONE IN MORPHINE-STABILIZED OPIOID ADDICTS

      Drug and alcohol dependence
    65. Greenwald, MK; Stitzer, ML
      Butorphanol agonist effects and acute physical dependence in opioid abusers: comparison with morphine

      DRUG AND ALCOHOL DEPENDENCE
    66. GHOSH S; PATEL AH; COUSINS M; GRASING K
      DIFFERENT EFFECTS OF OPIATE WITHDRAWAL ON DOPAMINE TURNOVER, UPTAKE, AND RELEASE IN THE STRIATUM AND NUCLEUS-ACCUMBENS

      Neurochemical research
    67. ELKADI AOS; SHARIF SI
      THE ROLE OF DOPAMINE IN THE EXPRESSION OF MORPHINE-WITHDRAWAL

      General pharmacology
    68. SINGEWALD N; PHILIPPU A
      RELEASE OF NEUROTRANSMITTERS IN THE LOCUS-COERULEUS

      Progress in neurobiology
    69. GURLEY RJ; ARANOW R; KATZ M
      MEDICINAL MARIJUANA - A COMPREHENSIVE REVIEW

      Journal of psychoactive drugs
    70. BERNIK MA; GORENSTEIN C; VIEIRA AHG
      STRESSFUL REACTIONS AND PANIC ATTACKS INDUCED BY FLUMAZENIL IN CHRONIC BENZODIAZEPINE USERS

      JOURNAL OF PSYCHOPHARMACOLOGY
    71. Olson, GA; Olson, RD; Vaccarino, AL; Kastin, AJ
      Endogenous opiates: 1997

      PEPTIDES
    72. FUKUNAGA Y; NISHIDA S; INOUE N; MIYAMOTO M; KISHIOKA S; YAMAMOTO H
      TIME-COURSE OF MORPHINE-WITHDRAWAL AND PREPROENKEPHALIN GENE-EXPRESSION IN THE PERIAQUEDUCTAL GRAY OF RATS

      Molecular brain research
    73. GRUBB MC; STORNETTA RL; PENCE R; BAERTSCHI AJ; GUYENET PG
      ANTAGONIST PRECIPITATED CLONIDINE WITHDRAWAL IN RAT - EFFECTS ON LOCUS-COERULEUS NEURONS, SYMPATHETIC-NERVES AND CARDIOVASCULAR PARAMETERS

      Journal of the autonomic nervous system
    74. PARKER LA; JOSHI A
      NALOXONE-PRECIPITATED MORPHINE-WITHDRAWAL INDUCED PLACE AVERSIONS - EFFECT OF NALOXONE AT 24 HOURS POSTMORPHINE

      Pharmacology, biochemistry and behavior
    75. WONGCHANAPAI W; TSANG BK; HE Z; HO IK
      RELATIVE INVOLVEMENT OF SPINAL OPIOID RECEPTORS IN PHYSICAL-DEPENDENCE ON INTRATHECAL BUTORPHANOL AND MORPHINE

      Pharmacology, biochemistry and behavior
    76. MARTIN JR; MOREAU JL; JENCK F; PIERI L
      SARMAZENIL-PRECIPITATED WITHDRAWAL - A RELIABLE METHOD FOR ASSESSING DEPENDENCE LIABILITY OF BENZODIAZEPINE RECEPTOR LIGANDS

      Pharmacology, biochemistry and behavior
    77. COLDWELL SE; KAUFMAN E; MILGROM P; KHARASCH ED; CHEN P; MAUTZ D; RAMSAY DS
      ACUTE TOLERANCE AND REVERSAL OF THE MOTOR CONTROL EFFECTS OF MIDAZOLAM

      Pharmacology, biochemistry and behavior
    78. POPIK P; MAMCZARZ J; FRACZEK M; WIDLA M; HESSELINK M; DANYSZ W
      INHIBITION OF REINFORCING EFFECTS OF MORPHINE AND NALOXONE-PRECIPITATED OPIOID WITHDRAWAL BY NOVEL GLYCINE SITE AND UNCOMPETITIVE NMDA RECEPTOR ANTAGONISTS

      Neuropharmacology
    79. CARON RW; LENG G; LUDWIG M; RUSSELL JA
      NALOXONE-INDUCED SUPERSENSITIVITY OF OXYTOCIN NEURONS TO OPIOID ANTAGONISTS

      Neuropharmacology
    80. PINEDA J; TORRECILLA M; MARTINRUIZ R; UGEDO L
      ATTENUATION OF WITHDRAWAL-INDUCED HYPERACTIVITY OF LOCUS-COERULEUS NEURONS BY INHIBITORS OF NITRIC-OXIDE SYNTHASE IN MORPHINE-DEPENDENT RATS

      Neuropharmacology
    81. MEDVEDEV IO; DRAVOLINA OA; BESPALOV AY
      EFFECTS OF N-METHYL-D-ASPARTATE RECEPTOR ANTAGONISTS ON DISCRIMINATIVE STIMULUS EFFECTS OF NALOXONE IN MORPHINE-DEPENDENT RATS USING THE Y-MAZE DRUG DISCRIMINATION PARADIGM

      The Journal of pharmacology and experimental therapeutics
    82. HOUTSMULLER EJ; WALSH SL; SCHUH KJ; JOHNSON RE; STITZER ML; BIGELOW GE
      DOSE-RESPONSE ANALYSIS OF OPIOID CROSS-TOLERANCE AND WITHDRAWAL SUPPRESSION DURING LAAM MAINTENANCE

      The Journal of pharmacology and experimental therapeutics
    83. DUNBAR SA; PULAI IJ
      REPETITIVE OPIOID ABSTINENCE CAUSES PROGRESSIVE HYPERALGESIA SENSITIVE TO N-METHYL-D-ASPARTATE RECEPTOR BLOCKADE IN THE RAT

      The Journal of pharmacology and experimental therapeutics
    84. Jhamandas, JH; Harris, KH; Petrov, T; Yang, HYT; Jhamandas, KH
      Activation of neuropeptide FF neurons in the brainstem nucleus tractus solitarius following cardiovascular challenge and opiate withdrawal

      JOURNAL OF COMPARATIVE NEUROLOGY
    85. ZHU H; ROCKHOLD RW; HO IK
      THE ROLE OF GLUTAMATE IN PHYSICAL-DEPENDENCE ON OPIOIDS

      Japanese Journal of Pharmacology
    86. LICHTMAN AH; WILEY JL; LAVECCHIA KL; NEVIASER ST; ARTHUR DB; WILSON DM; MARTIN BR
      EFFECTS OF SR 141716A AFTER ACUTE OR CHRONIC CANNABINOID ADMINISTRATION IN DOGS

      European journal of pharmacology
    87. ZHU H; HO IK
      NMDA-R1 ANTISENSE OLIGONUCLEOTIDE ATTENUATES WITHDRAWAL SIGNS FROM MORPHINE

      European journal of pharmacology
    88. RABADAN JV; MILANES MV; LAORDEN ML
      CHANGES IN RIGHT ATRIAL CATECHOLAMINE CONTENT IN NATIVE RATS AND AFTER NALOXONE-INDUCED WITHDRAWAL

      British Journal of Anaesthesia
    89. Kimes, AS; Maldonado, R; Ambrosio, E; Koob, GF; London, ED
      Cerebral glucose metabolism during opioid withdrawal following methylnaloxonium injection into the locus coeruleus

      BRAIN RESEARCH
    90. SCHLAEPFER TE; STRAIN EC; GREENBERG BD; PRESTON KL; LANCASTER E; BIGELOW GE; BARTA PE; PEARLSON GD
      SITE OF OPIOID ACTION IN THE HUMAN BRAIN - MU-AGONIST AND KAPPA-AGONIST SUBJECTIVE AND CEREBRAL BLOOD-FLOW EFFECTS

      The American journal of psychiatry
    91. KIENBAUM P; THURAUF N; MICHEL MC; SCHERBAUM N; GASTPAR M; PETERS J
      PROFOUND INCREASE IN EPINEPHRINE CONCENTRATION IN PLASMA AND CARDIOVASCULAR STIMULATION AFTER MU-OPIOID RECEPTOR BLOCKADE IN OPIOID-ADDICTED PATIENTS DURING BARBITURATE-INDUCED ANESTHESIA FOR ACUTE DETOXIFICATION

      Anesthesiology
    92. PINELLI A; TRIVULZIO S
      QUANTITATIVE-EVALUATION OF OPIOID WITHDRAWAL SIGNS IN RATS REPEATEDLYTREATED WITH MORPHINE AND INJECTED WITH NALOXONE, IN THE ABSENCE OR PRESENCE OF THE ANTIABSTINENCE AGENT CLONIDINE

      Journal of pharmacological and toxicological methods
    93. ERNST M; LONDON ED
      BRAIN IMAGING STUDIES OF DRUG-ABUSE - THERAPEUTIC IMPLICATIONS

      Seminars in the neurosciences
    94. REZAYAT M; AZIZI N; ZARRINDAST MR
      ON THE MECHANISM(S) OF CHOLECYSTOKININ (CCK) - RECEPTOR STIMULATION ATTENUATES MORPHINE-DEPENDENCE IN MICE

      Pharmacology & toxicology
    95. EISSENBERG T; JOHNSON RE; BIGELOW GE; WALSH SL; LIEBSON IA; STRAIN EC; STITZER ML
      CONTROLLED OPIOID WITHDRAWAL EVALUATION DURING 72 H DOSE OMISSION IN BUPRENORPHINE-MAINTAINED PATIENTS

      Drug and alcohol dependence
    96. PUNCH LJ; SELF DW; NESTLER EJ; TAYLOR JR
      OPPOSITE MODULATION OF OPIATE WITHDRAWAL BEHAVIORS ON MICROINFUSION OF A PROTEIN-KINASE-A INHIBITOR VERSUS ACTIVATOR INTO THE LOCUS-COERULEUS OR PERIAQUEDUCTAL GRAY

      The Journal of neuroscience
    97. MALDONADO R
      PARTICIPATION OF NORADRENERGIC PATHWAYS IN THE EXPRESSION OF OPIATE WITHDRAWAL - BIOCHEMICAL AND PHARMACOLOGICAL EVIDENCE

      Neuroscience and biobehavioral reviews
    98. WILLIAMSHEMBY L; PORRINO LJ
      II - FUNCTIONAL CONSEQUENCES OF INTRAGASTRICALLY ADMINISTERED ETHANOLIN RATS AS MEASURED BY THE 2-[C-14]DEOXYGLUCOSE METHOD - THE CONTRIBUTION OF DOPAMINE

      Alcoholism, clinical and experimental research
    99. SALEM A; HOPE W
      EFFECT OF ADENOSINE RECEPTOR AGONISTS AND ANTAGONISTS ON THE EXPRESSION OF OPIATE WITHDRAWAL IN RATS

      Pharmacology, biochemistry and behavior
    100. SALEM A; HOPE W
      ROLE OF MORPHINE GLUCURONIDE METABOLITES IN MORPHINE-DEPENDENCE IN THE RAT

      Pharmacology, biochemistry and behavior


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/05/20 alle ore 12:41:05